Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Jyong Biotech Ltd. - Ordinary shares (NQ:MENS)

40.01 -9.99 (-19.98%)
Streaming Delayed Price Updated: 3:24 PM EDT, Oct 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Jyong Biotech Ltd. - Ordinary shares

Top stock movements in today's session.
Let's have a look at what is happening on the US markets in the middle of the day on Tuesday. Below you can find the top gainers and losers in today's session. 
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
Trump Sparks A 2025 IPO Boom: 5 New Stocks Have Rallied Over 400%
Trump's second term is fueling an IPO comeback, with 2025 listings up 50% and five stocks already soaring over 400% post-debut. 
Via Benzinga
Topics Government Initial Public Offering
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
Let's have a look at the top gainers and losers in the middle of the day of today's session.
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
These Were the 5 Top-Performing Stocks in the Nasdaq Composite in August 2025
Almost all of it was event-driven, while the bulk of these gains were made by small biopharma names. 
Via The Motley Fool
Topics Intellectual Property Stocks
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.